Start here if you're new
what it is
Accenture helps big companies change their tech, then gets paid to run parts of it afterward.
how it gets paid
Fiscal 2025 revenue was $69.67B (Form 10-K, year ended Aug 31, 2025). By industry group, Products was largest at ~$21.2B; Health & Public Service ~$14.8B (~21%).
why it's growing
FY25 revenue rose ~7.4% from $64.90B in FY24 — a normal large-cap pace, not triple-digit noise. Demand themes in filings center on digital, cloud, data, and AI-related services.
what just happened
Q2 FY26 (quarter ended Feb 28, 2026): revenue $18.04B, up ~8.3% from $16.66B in Q2 FY25. Diluted EPS $2.93 vs. $2.82 prior-year quarter (Form 10-Q filed Mar 19, 2026).
At a glance
A+ balance sheet — rock-solid finances — built to survive anything
100/100 earnings predictability — you can trust these numbers
~23.6x trailing P/E (illustrative: ~$286 ÷ FY25 diluted EPS $12.15) · verify
2.3% dividend yield — cash in your pocket every quarter
ROE mid-20%s range (FY25 illustrative — definition-sensitive)
xvary composite: 84/100 — above average
What they do
Accenture helps big companies change their tech, then gets paid to run parts of it afterward.
Accenture sits in the middle of expensive corporate change programs, and switching costs are real once work is underway. The FY25 10-K cites roughly 779,000 people — scale smaller rivals cannot match when clients want strategy, technology, and managed services together. Consulting wins transformation programs; managed services (outsourcing) adds recurring revenue.
How they make money
$69.67B
fiscal 2025 revenue · +~7.4% vs. fiscal 2024 ($64.90B) — SEC Form 10-K
Products (industry group)
$21.2B
Health & Public Service
$14.8B
Financial Services
$12.8B
Communications, Media & Technology
$11.5B
Resources
$9.5B
source: SEC Form 10-K FY2025 (year ended Aug 31, 2025), revenue by industry group — XBRL
The products that matter
strategy, technology & transformation projects
Consulting
~$35.1B FY25 · largest revenue type
Consulting revenue slightly edges managed services in FY25 (~$35.1B vs. ~$34.6B) per 10-K — this is the project engine that opens the door to long-running client work.
largest line
managed IT & business operations
Managed services
~$34.6B FY25 · recurring execution
Managed services (historically “outsourcing”) is the recurring revenue companion to consulting — similar scale, different cadence.
recurring base
largest industry vertical by revenue
Products
~$21.2B FY25 · Products industry group
The Products industry group is the largest industry slice at ~$21.2B in FY25 — tied to broad corporate IT and operations spend. Budget cuts often show up here first.
budget exposure
serves tech and media clients
Communications, Media & Technology
~$11.5B revenue · ~16% of FY25 sales
Communications, media, and technology is where cloud, software, and AI-related demand often shows up first. If tech budgets stall, this group is an early read.
ai read-through
Key numbers
$13.80
FY2026 EPS est
Third-party consensus — not from SEC filings. Verify before modeling.
$74B
FY2026 rev est
Third-party consensus — not from SEC filings.
~23.6x
trailing P/E
Illustrative: ~$286 ÷ FY25 diluted EPS $12.15 (10-K). Price moves daily.
2.3%
dividend yield
Illustrative only — yield = f(dividends, price). Confirm with your data source.
Financial health
A+
strength
- balance sheet grade A+ — near the highest rating possible
- risk rank 2 — safer than 80% of stocks
- price stability 80 / 100
- long-term debt & leases ~$5.0B non-current (Feb 28, 2026 balance sheet · 10-Q)
- net profit margin ~11% — FY25 net income ~$7.68B on ~$69.67B revenue (10-K)
- return on equity ~25% — order-of-magnitude using FY25 net income vs. year-end equity (verify your definition)
A+ reflects scale and balance-sheet capacity vs. most public companies — still read the latest 10-Q/10-K for debt, cash, and client concentration.
Total return vs. market
Total return vs. an index is not computed on this page — figures were removed in L3 because they were not tied to a single audited filing line.
source: n/a on-page — verify externally
What just happened
filing + narrative
Q2 FY26 (quarter ended Feb 28, 2026): revenue $18.04B, up ~8.3% vs. prior year. Diluted EPS $2.93 vs. $2.82 in Q2 FY25 (Form 10-Q filed Mar 19, 2026).
Gross margin (revenue less cost of services) was ~30.3% for the quarter per reported lines — not 33%. “AI bookings” and sequential comparisons are management metrics from earnings materials, not a standard GAAP line; verify wording in the press release / investor deck.
$18.04B
Q2 FY26 revenue
$2.93
diluted EPS
~30.3%
gross margin (Q2)
the number that mattered
For filing purists, the hard print is $18.04B / $2.93. For sentiment, many holders still track company-disclosed AI bookings — treat those as supplemental, not audited facts.
-
accenture continued to benefit from secular tailwinds in technology.
-
the company realized 6% vs. prior year revenue growth in the november period, with technology platform businesses contributing 60% of the top-line total.
-
there has been elevated demand for application modernization and cloud integration.this has aligned well with strong client interest in generative artificial intelligence (AI) tools that create digital media based on human-provided prompts.
-
ai-related quarterly bookings declined from $2.7 billion in the fiscal 2025 fourth quarter to $2.2 billion in the fiscal 2026 first quarter (year ends august 31st).
-
meanwhile, the european region remains sluggish due to macroeconomic uncertainty.
source: SEC Form 10-Q accession 0001467373-26-000014 (Mar 19, 2026) · supplemental metrics per company earnings materials
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the central risk here is specific, not theoretical: AI bookings fell from $2.7B to $2.2B while management still guided only 2–5% local currency growth. if that combination sticks, the stock stops looking like an AI beneficiary and starts looking like what it already is — a very good consulting business with modest growth.
med
AI demand that looks better in bookings than in revenue
If company-disclosed AI bookings stay soft, sentiment can cool even when GAAP results look fine. Multiples in the low-20s on trailing earnings (illustrative ~23.6× on FY25 EPS) already bake in quality.
That matters when revenue growth is guided to a low single-digit range in local currency — there is not much room for a narrative miss.
med
federal weakness on top of already cautious guidance
management has already flagged U.S. federal business weakness as a drag. when the full-company growth guide is 2–5%, you do not need a dramatic slowdown for sentiment to sour.
if growth keeps hugging the low end of that range, investors stop paying up for consistency and start asking why they own the stock instead of the index.
med
europe stays sluggish
EMEA was about $24.6B of FY25 geographic revenue (10-K) — too large to dismiss as noise when macro is uneven.
if europe stays weak, stronger pockets elsewhere have to work harder just to keep consolidated growth respectable.
med
acquisition integration pressure
Accenture routinely acquires boutiques and capability plays. The balance sheet can usually absorb it, but integration still risks client disruption and margin leakage.
Operating margin was ~13.8% in Q2 FY26 and ~14.7% for FY25 — strong, but not immune to wage pressure and deal friction.
If AI-related momentum in bookings slows while Europe stays heavy, you still own a high-quality services compounder — but at ~mid-teens operating margins and a mid-20s trailing multiple on FY25 EPS, the bar for sentiment is higher than for a deep-value name.
source: SEC 10-K/10-Q (cited figures) · management guidance & KPIs from earnings materials
Pay attention to
earnings
next quarter's AI bookings print
$2.2B is the current number. you want to see whether it climbs back toward the prior $2.7B quarter or slips again.
trend
growth versus the 2–5% guide
this stock can live with moderate growth. it struggles when the market decides even that guide was generous.
metric
EMEA ~$24.6B FY25 revenue
Geographic mix matters: Americas ~$35.1B, EMEA ~$24.6B, Asia Pacific ~$10.0B in FY25 (10-K). EMEA softness hits consolidated growth quickly.
risk
margin discipline
Watch operating margin through the year — Q2 FY26 was ~13.8% on revenue of $18.04B (10-Q). Hiring, mix, and acquisition integration move that line.
Analyst rankings
short-term outlook
top 20%
momentum score 2 — analysts expect above-average price performance in the year ahead. in human-speak, they think ACN still has enough quality and stability to beat most stocks from here.
risk profile
safer than most
stability score 2 — safer than roughly 80% of stocks. this is not where you go for drama.
chart momentum
below average
technical score 4 — the chart has been less convincing than the business.
earnings predictability
100 / 100
management gives reliable guidance. surprise is rare here, for better and worse.
source: institutional data
Institutional activity
Institutional ownership flows are not verified here against a primary filing line (13F aggregation varies by vendor). Treat headline buyer/seller counts as third-party screens, not SEC facts.
source: institutional data
Price targets
3-5 year target range
$233
$390
$286
current price
$312
target midpoint · +9% from current · 3-5yr high: $445 (+55% · 12% ann'l return)
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive